• HeartCore completed the divestiture of its 51% stake in Sigmaways to a third party, including assignment of intercompany loans and receivables.
• Transaction removes a loss-making, non-core unit acquired in 2023 that had faced revenue declines and persistent operating losses.
• Sigmaways carried a shareholders’ deficit of about USD 3.6 million as of March 31, 2026, weighing on consolidated equity.
• HeartCore expects lower exposure to future losses and working-capital needs, sharpening focus on Go IPO consulting and related advisory expansion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HeartCore Enterprises Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606250830PRIMZONEFULLFEED9752364) on June 25, 2026, and is solely responsible for the information contained therein.